Curefit scoops up Rs 832 crore in fresh round led by Temasek

NEW DELHI: Curefit has raised an estimated Rs 832 crore in fresh funding, in a round led by Temasek.

The new financing round, first reported by Entrackr, has also seen the entry of two new investors into the company’s investor cap table, GableHorn Investments and Ascent Capital.

Additionally, several existing investors of Curefit, which includes venture capital firms Accel Partners and Chiratae Ventures, along with investment arm Unilever, have also participated in the latest funding round.